Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
NCT01389895
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class
Stopped
slow enrollment
Conditions
Cutaneous Lupus
Lupus
Interventions
DRUG:
AMG 557
DRUG:
AMG 557 Placebo
Sponsor
Amgen